By Adi Hoess, CEO of Affimed I know how critical it is to be measured when setting expectations. In business, as in life, none of us aspire to overpromise and under-deliver. Indeed, as any business venture must do when communicating with investors and the public, we at Affimed are careful to use so-called “forward-looking statements”…
Lonza and CN Bio announce distribution agreement providing prevalidated hepatocytes for use on innovative organ-on-a-chip range
Lonza and CN Bio have entered into a distribution agreement whereby Lonza will supply a selection of hepatic cells to be prequalified by CN Bio for use in their PhysioMimix Single-and Multi-Organ MPS to transform the way human-relevant pre-clinical data is generated. With prequalified cells, customers can avoid having to trial numerous cell types to…
MOBIE accelerates biotherapeutic drug development and multiomic biomarker discovery
MOBILion Systems has launched MOBIE, the first commercial High-Resolution Ion Mobility (HRIM) product that addresses characterization challenges faced during biopharmaceutical drug development and quality monitoring. MOBIE provides fast, efficient separations with superior resolution and reproducibility, faster, simpler method development and greater instrument uptime. This highly anticipated new technology will help accelerate and simplify the workflows…
Eikon Therapeutics secures $148M to develop advanced microscopy for drug discovery
Eikon Therapeutics has announced that it has closed a $148 million Series A financing led by The Column Group with participation from Foresite Capital, Innovation Endeavors and Lux Capital. The company also announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as its new CEO. Eikon’s drug discovery platform evolved from super-resolution microscopy, a ground-breaking…
PerkinElmer expands Signals Informatics capabilities in biologics drug discovery
PerkinElmer announced this week its documentation, workflow and decision-making Signals informatics platform is being expanded to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with life science software company, Insightful Science. With the collaboration, pharmaceutical and academic research teams can bring together the power of the PerkinElmer Signals…
2021 Global R&D Funding Forecast released
By Tim Studt, Contributing Editor For 62 years, R&D World and its predecessors have published an annual R&D funding forecast. These reports predict the combined dollar amount of R&D investments expected by industry, government and academia for the upcoming calendar year. Over those years, the publications these reports have appeared in have changed their ownership…